0187-3013 : Mestinon 180 mg Extended Release Tablet


NDC: 0187-3013
Labeler: Valeant Pharmaceuticals North America LLC
Product Type: Human Prescription Drug
Drug Name:  Mestinon
Dosage Form: Oral Tablet, Extended Release
Application #: NDA011665
Rev. Date: 


Appearance:


Markings: MES;V;180
Shapes:  Oval
Colors:  Yellow
Size (mm): 19
Segments: * 2

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces.

MES V 180: (0187-3013) Mestinon 180 mg Extended Release Tablet by Valeant Pharmaceuticals North America LLC
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.

NDC Package Codes:

  • 0187-3013-30: 30 TABLET, EXTENDED RELEASE IN 1 BOTTLE (0187‑3013‑30)

Active Ingredients:

  • Pyridostigmine Bromide

Dosage Strength:

  • 180 mg

Inactive Ingredients:

  • Carnauba Wax
  • Magnesium Stearate
  • Silicon Dioxide
  • Tribasic Calcium Phosphate

Pharmaceutical Classes:

  • Cholinesterase Inhibitor [EPC]
  • Cholinesterase Inhibitors [MoA]

Related Products:

Based on records with the same trade name.
  • 0187-3010 Mestinon 60 mg Oral Tablet by Valeant Pharmaceuticals North America LLC
  • 0187-3012 Mestinon 60 mg/5ml Oral Syrup by Valeant Pharmaceuticals North America LLC

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0187-3013 QR Code

< Prev: 0187-3012Next: 0187-3050 >

Related Discussions:

Pyridostigmine for myasthenia gravis
Is this the only medication for treating myasthenia gravis? ## I was only asking if there was anything else a person can... 2 replies
Is Mestinon the right drug for me?
I would like to hear what side effects others have while taking Mestinon. I'm not sure if I was prescribed this medi... 2 replies
Mestinon prescribed for Neurocardiogenic Syncopy
My daughter has tried all the other drug options and her Cardiologist has been thinking about trying Mestinon. Any comme...
mestinontimespanval
for:myastheniagravis...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.